Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional …

H Matsuoka, K Tagami, K Ariyoshi… - Japanese journal of …, 2019 - academic.oup.com
Cancer-related neuropathic pain (CNP) requires therapy involving multiple pharmaceuticals,
including anticonvulsants and antidepressants; however, strong evidence to support this …

Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional …

H Matsuoka, K Tagami, K Ariyoshi… - Japanese journal of …, 2019 - opus.lib.uts.edu.au
Cancer-related neuropathic pain (CNP) requires therapy involving multiple pharmaceuticals,
including anticonvulsants and antidepressants; however, strong evidence to support this …

Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: A nationwide cross-sectional …

H Matsuoka, K Tagami, K Ariyoshi… - … Journal of Clinical …, 2019 - tohoku.elsevierpure.com
Cancer-related neuropathic pain (CNP) requires therapy involving multiple pharmaceuticals,
including anticonvulsants and antidepressants; however, strong evidence to support this …

Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional …

H Matsuoka, K Tagami, K Ariyoshi… - … journal of clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Cancer-related neuropathic pain (CNP) requires therapy involving multiple pharmaceuticals,
including anticonvulsants and antidepressants; however, strong evidence to support this …

Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional …

H Matsuoka, K Tagami, K Ariyoshi… - … Journal of Clinical …, 2019 - search.ebscohost.com
Cancer-related neuropathic pain (CNP) requires therapy involving multiple pharmaceuticals,
including anticonvulsants and antidepressants; however, strong evidence to support this …

[引用][C] Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross …

H Matsuoka, K Tagami, K Ariyoshi, S Oyamada… - Japanese Journal of …, 2019 - cir.nii.ac.jp
Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related
neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey | CiNii …

Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional …

H Matsuoka, K Tagami, K Ariyoshi… - Japanese Journal of …, 2019 - academic.oup.com
Cancer-related neuropathic pain (CNP) requires therapy involving multiple pharmaceuticals,
including anticonvulsants and antidepressants; however, strong evidence to support this …

Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional …

H Matsuoka, K Tagami, K Ariyoshi… - Japanese Journal of …, 2019 - europepmc.org
Cancer-related neuropathic pain (CNP) requires therapy involving multiple pharmaceuticals,
including anticonvulsants and antidepressants; however, strong evidence to support this …